Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rituximab Maintenance”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)Study completedNCT00738829
What this trial is testing

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Arbeitsgemeinschaft medikamentoese Tumortherapie 45
Testing effectiveness (Phase 2)WithdrawnNCT00004040
What this trial is testing

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)UnknownNCT05596097
What this trial is testing

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
LanZhou University 15
Testing effectiveness (Phase 2)Study completedNCT01754857
What this trial is testing

Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL

Who this might be right for
Lymphoid LeukemiaSmall Lymphocytic LymphomaLymphoma, Non-Hodgkin
University of Wisconsin, Madison 36
Testing effectiveness (Phase 2)Study completedNCT00433537
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma

Who this might be right for
Contiguous Stage II Mantle Cell LymphomaNoncontiguous Stage II Mantle Cell LymphomaStage I Mantle Cell Lymphoma+2 more
National Cancer Institute (NCI) 77
Testing effectiveness (Phase 2)Study completedNCT01560117
What this trial is testing

Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma

Who this might be right for
Follicular T-NHL LymphomaRituximab Maintenance
Arbeitsgemeinschaft medikamentoese Tumortherapie 29
Post-approval studies (Phase 4)Looking for participantsNCT06906549
What this trial is testing

Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Rituximab (RTx)
University Hospital, Strasbourg, France 260
Large-scale testing (Phase 3)Study completedNCT00645606
What this trial is testing

Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
University Hospital, Tours 542
Testing effectiveness (Phase 2)Study completedNCT00974233
What this trial is testing

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
University of Wisconsin, Madison 34
Large-scale testing (Phase 3)Study completedNCT00227695
What this trial is testing

Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 270
Testing effectiveness (Phase 2)WithdrawnNCT01754870
What this trial is testing

Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
University of Wisconsin, Madison
Testing effectiveness (Phase 2)UnknownNCT01329354
What this trial is testing

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy

Who this might be right for
Follicular LymphomaFollicular Non-Hodgkin´s LymphomaAutologous Effector Lymphocytes
Clinica Universidad de Navarra, Universidad de Navarra 38
Testing effectiveness (Phase 2)Study completedNCT01241734
What this trial is testing

Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Hackensack Meridian Health 18
Post-approval studies (Phase 4)Study completedNCT02858804
What this trial is testing

EDOCH Alternating With DHAP for New Diagnosed Younger MCL

Who this might be right for
Mantle Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 55
Testing effectiveness (Phase 2)Ended earlyNCT00582166
What this trial is testing

Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance

Who this might be right for
Non-Hodgkin's Lymphoma
University of Wisconsin, Madison 18
Large-scale testing (Phase 3)Study completedNCT01200758
What this trial is testing

Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 410
Post-approval studies (Phase 4)Looking for participantsNCT05898308
What this trial is testing

Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

Who this might be right for
PemphigusDermatologic Disease
University Hospital, Rouen 133
Large-scale testing (Phase 3)Study completedNCT00718549
What this trial is testing

Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 128
Testing effectiveness (Phase 2)Ended earlyNCT01313611
What this trial is testing

BRIEF Bendamustine and Rituximab In Elderly Follicular

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 62
Large-scale testing (Phase 3)Study completedNCT01461928
What this trial is testing

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 692
Next Page